tarenflurbil: Clinical Trials

6 trials of tarenflurbil, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated, 1 unknown. 3 Phase 3, 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 33Terminated 2, Completed 1
Phase 22Completed 1, Unknown 1
Phase 11Completed 1

Follow tarenflurbil: new trials by email Literature Review of tarenflurbil trials Research Report on tarenflurbil

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TMP001 in Relapsing-remitting Multiple Sclerosis
TMP001 - Remitting-Relapsing Multiple Sclerosis
Phase 2CompletedDr. Frank Behrens92015-08-012018-11-21
Bioavailability, Pharmacokinetics and Tissue Distribution of R-flurbiprofen Capsules in Healthy Subjects
R-flurbiprofen - Healthy Volunteers
Phase 1CompletedGerd Geisslinger162014-06-012015-09-11
Open-Label Treatment With MPC-7869 for Patients With Alzheimer's Who Previously Participated in an MPC-7869 Protocol
MPC-7869 - Alzheimer's Disease
Phase 3TerminatedMyrexis Inc.10002006-09-012008-08-05
Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
MPC-7869 - Alzheimer Disease, Dementia
Phase 3TerminatedMyrexis Inc.8002006-05-012008-08-05
Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
MPC-7869 - Alzheimer Disease, Dementia
Phase 3CompletedMyrexis Inc.16002005-02-012009-05-05
R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
tarenflurbil, adjuvant therapy - Prostate Cancer
Phase 2UnknownMyrexis Inc.2002-02-012013-12-18

Conditions studied

Alzheimer Disease (3)  ·  Dementia (3)  ·  Multiple Sclerosis (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Prostatic Neoplasms (1)

Sponsors

Myrexis Inc. (4)  ·  Dr. Frank Behrens (1)  ·  Gerd Geisslinger (1)

Countries

United States (4)  ·  Germany (3)  ·  Canada (2)  ·  Belgium (1)  ·  Denmark (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Sweden (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Mark Laughlin, MD (2)  ·  Ed Swabb, MD (1)  ·  Gerd Geisslinger, Prof MD (1)  ·  Sheron B. Bass, RN, MS (1)  ·  Ulf Ziemann, MD (1)

Results publications

PMID 20009055